
Labs in Court
In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.
In recent key cases, the national drug retailer must stand trial for failing to protect customers from faulty Theranos products.
A recent False Claims Act settlement from Kentucky represents an unusual variation on a common theme.
Last week’s three key cases included two involving drug testing that was either medically unnecessary, or not provided at all.
In addition to the usual FCA-related fare, an arrest warrant was issued for a convicted lab co-owner after he failed to show up for prison.
Two companies settle kickback and FCA-related claims, a qui tam case is tossed, and a lab tech loses a workplace harassment case.